Why open source pharma is the path to both cheaper and new medicines | Matthew Todd

Breaking the cycle in which only highly profitable drugs reach the market is not just the responsibility of government

We can all agree that we have some life-saving medicines available to us. We may have benefited directly, or have family members who are benefiting at the moment.

Some medicines, however, are too expensive. Some don't work too well and there are, of course, many terrible diseases for which we have no medicines at all. These issues affect rich and poor nations alike.